MYD Analysis

Myriad Genetics, Inc.
Stock Exchange: XETRA
Sector: biotechnology
23.7
Last session price
23.7
Price now
Currency: EUR
Reporting currency: USD
ISIN: US62855J1043
INN:
.

MYD financial statements

* Numbers in millions
Capitalization * 1 761
EV * 821
Number of shares * 74
EPS -2,69
Revenue * 639
Net income * -200
Operating profit * -135
Total liabilities * 486
Net debt * 115
Total assets * 1 405
Equity * 918
Cash and investments * 218
.

MYD valuation

P/E -8,83
P/B 1,92
P/S 2,76
E/P -11
P/FCF 34,87
.

MYD profitability

ROE -22%
ROA% -42%
ROIC% -11%